Article

Mumbai Eye Care Campaign launched to prevent blindness

Sightsavers International has launched the Mumbai Eye Care Campaign to prevent avoidable blindness and to offer eye care to millions of Mumbai's citizens in underserved areas of the city, such as Dharavi, the setting of the award-winning film, 'Slumdog Millionaire.'

Mumbai, India-Sightsavers International has launched the Mumbai Eye Care Campaign to prevent avoidable blindness and to offer eye care to millions of Mumbai’s citizens in underserved areas of the city, such as Dharavi, the setting of the award-winning film, “Slumdog Millionaire.”

Standard Chartered Bank has committed $1 million to the campaign as part of its community investment program, Seeing is Believing. Funds raised from this campaign will go to improving the vision of the most vulnerable groups, such as women and children as well as people with low socio-economic status.

"With so much of our business in the developing world, avoidable blindness is a major problem in many of our markets,” said Joanna Conlon, program manager, Seeing is Believing. “And it is not just a health issue: it is also an economic issue, depriving those affected of education and a job, and often rendering them economically dependent.”

The campaign will try to solve the growing problem of refractive error, which is the second leading cause of blindness in India. About 1.4 million people in India are effectively blind and in need of glasses.

"The global success of ‘Slumdog Millionaire’ has brought the reality of daily life in the urban areas, such as Dharavi, to the world's attention,” said Elizabeth Kurian, regional director, Sightsavers India. “The Mumbai Eye Care Campaign will bring fast and long-lasting benefits and services to as many as 1 million of Mumbai's less-well-off individuals.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.